NEW YORK (Reuters Health) – Although dimenhydrinate can reduce vomiting in children with acute gastroenteritis, it does not improve oral rehydration or clinical outcomes, according to a report…
NEW YORK (Reuters Health) – Darusentan, a selective endothelin-receptor blocker, can reduce blood pressure in patients who have not reached their target levels using three or more antihypertensive…
NEW YORK (Reuters Health) – New guidelines issued jointly by the American Academy of Neurology and the Child Neurology Society point out that children with microcephaly are at…
NEW YORK (Reuters Health) – Findings from a systematic review indicate that while tamoxifen, raloxifene, and tibolone all reduce the risk of primary breast cancer, the drugs differ…
NEW YORK (Reuters Health) – A dexamethasone-based protocol can cut the risk of relapse and improve survival in high-risk children with acute lymphoblastic leukemia (ALL), with fewer side…
NEW YORK (Reuters Health) – Thiazolidinedione treatment of diabetes in older adults is associated with an increased fracture risk, according to a report in the August issue of…
NEW YORK (Reuters Health) – Intracoronary streptokinase (ICSK) given immediately after percutaneous coronary intervention (PCI) reduces long-term myocardial infarction size and improves left ventricular volumes and function, Turkish…
NEW YORK (Reuters Health) – When metformin and a sulphonylurea or a glinide fail to bring type 2 diabetes under control, adding pioglitazone may do the trick, French…
NEW YORK (Reuters Health) – Rectal diclofenac, oral ibuprofen, and oral acetaminophen are ineffective for preventing recurrences of febrile seizures in children, new research suggests. Moreover, such agents…
NEW YORK (Reuters Health) – Doubling the standard dose of fluvestrant improves the efficacy of the drug against breast cancer without affecting tolerability, new research suggests. Moroever, at…
